Price Alert

Thermo Fisher Scientific ... (TMO)

NYSE: TMO · Real-Time Price · USD

492.95

3.21 (0.66%)

At close: Aug 29, 2025, 3:59 PM

493.00

0.01%

After-hours: Aug 29, 2025, 06:23 PM EDT

0.66% (1D)

Bid	490.7
Market Cap	186.14B
Revenue (ttm)	43.21B
Net Income (ttm)	6.58B
EPS (ttm)	17.28
PE Ratio (ttm)	28.53
Forward PE	20.01
Analyst	Buy

Ask	495
Volume	911,712
Avg. Volume (20D)	2,657,766
Open	489.94
Previous Close	489.74
Day's Range	485.92 - 494.28
52-Week Range	385.46 - 627.88
Beta	0.75

About TMO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol TMO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TMO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Thermo Fisher Scientific Inc. is scheduled to release its earnings on Oct 22, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+1.78%

Thermo Fisher Scientific shares are trading higher... Unlock content with Pro Subscription

1 month ago

+9.14%

Thermo Fisher Scientific shares are trading higher after the company reported better-than-expected Q2 financial results.

News

1 day ago · zacks.com

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio?

TMO's growth, driven by new partnerships and strong end markets, faces challenges from macro pressures and fierce competition.

1 day ago · seekingalpha.com

mRNA Biotechs - Long-Term Value Risks Abound

mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery c...

1 week ago · zacks.com

Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock?

1 week ago · businesswire.com

Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its innovative manufacturing center of excellence facility in ...

1 week ago · fool.com

Why Thermo Fisher Scientific Stock Was Topping the Market Today

An analyst launched coverage of Thermo Fisher Scientific (TMO 2.15%) after market close on Monday, and the stock was experiencing a little pop the following day as a result. On Tuesday, it closed more...

1 week ago · benzinga.com

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Could Thermo Fisher Scientific Inc. TMO be the unsung hero of the biopharma sector's future? While its stock performance has recently lagged, analysts are betting on a major turnaround driven by strat...

2 weeks ago · zacks.com

TMO Receives FDA Approval for Oncomine Dx Target Test

Thermo Fisher secures FDA approval for its Oncomine Dx Target Test to identify NSCLC patients eligible for HERNEXEOS treatment.

2 weeks ago · youtube.com

Final Trades: Toast, Transdigm, Thermo Fisher and Amazon

The Investment Committee give you their top stocks to watch for the second half.

2 weeks ago · seekingalpha.com

Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside

Revenue growth is accelerating, led by pharma/biotech momentum and bioproduction demand. The medium-term margin outlook is positive with cost cuts, AI-driven efficiencies, and lapping of tariff headwi...

2 weeks ago · businesswire.com

Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Oncomine Dx Target Test...

Load More News